Enterobacter spp
Results from all hospitals
Blood isolates
(January-June 2002)

WARDS
Drug
Isolates tested
% Not
susceptible
%R
%I
Cefoxitin
69
92,75%
91,30%
1,45%
 
 
 
 
 
Cefotaxime
72
59,72%
51,39%
8,33%
 
 
 
 
 
Ceftazidime
70
58,57%
57,14%
1,43%
Ceftriaxone
41
56,10%
51,22%
4,88%
Aztreonam
46
54,35%
52,17%
2,17%
 
 
 
 
 
Cefepime
43
25,58%
20,93%
4,65%
 
 
 
 
 
Imipenem
70
4,29%
4,29%
0,00%
 
 
 
 
 
Gentamicin
72
13,89%
6,94%
6,94%
Tobramycin
69
34,78%
33,33%
1,45%
Amikacin
71
16,91%
12,68%
4,23%
Netilmicin
45
20,00%
20,00%
0,00%
 
 
 
 
 
Chloramphenicol
23
8,70%
8,70%
0,00%
Tetracycline
16
25,00%
12,50%
12,50%
Cotrimoxazole
72
51,39%
50,00%
1,39%
 
 
 
 
 
Nalidixic acid
38
31,58%
31,58%
0,00%
Ciprofloxacin
69
33,33%
24,64%
8,70%
    
ICU
Isolates tested
% Not
susceptible
%R
%I
18
94,44%
94,44%
0,00%
 
 
 
 
17
94,12%
94,12%
0,00%
 
 
 
 
18
88,89%
88,89%
0,00%
11
90,91%
81,82%
9,09%
16
93,75%
93,75%
0,00%
 
 
 
 
14
64,29%
35,71%
28,57%
 
 
 
 
18
5,56%
5,56%
0,00%
 
 
 
 
18
44,44%
38,89%
5,56%
17
70,59%
64,71%
5,88%
18
33,33%
22,22%
11,11%
13
61,54%
61,54%
0,00%
 
 
 
 
5
80,00%
40,00%
40,00%
7
71,43%
42,86%
28,57%
18
77,78%
77,78%
0,00%
 
 
 
 
9
77,78%
77,78%
0,00%
18
66,67%
66,67%
0,00%